ABSTRACT: Osteomyelitis is a frequent consequence of open fractures thus representing a common bone infection with subsequent alteration of bone regeneration. Impaired bone homeostasis provokes serious variations in the bone remodeling process, thereby involving multiple inflammatory cytokines to activate bone healing. Our previously established mouse model of posttraumatic osteomyelitis provides the chance to study regulation of selected cytokines after surgical debridement of osteomyelitis thus illustrating the course of initial infectious recovery. An inflammatory cytokine array revealed specifically upregulated cytokines in debrided animals after bone infection, that were verified by Western blot analysis, identifying increased levels of CCL2, CCL3, and CXCL2. Increased osteoclastogenesis after debridement of osteomyelitis was demonstrated by Calcitonin-receptor and RANKL detection via immunohistochemical and -fluorescence stainings. The substantial protein analysis was complemented by uncovering diminished osteogenesis and proliferation in debrided group, tracking Osteocalcin, RUNX2, and PCNA expression. Interestingly TNF-a expression seemed to have no effect on altered bone regeneration after bone infection. Additional flow cytometry analysis proved elevated B cell activity, subsequently increased osteoclast activity and accelerated bone resorption. Based on the variety of severely altered cytokines, we propose a RANKL-dependent osteoclastogenesis after debridement of osteomyelitis coinciding with elevated B cells and simultaneously decreased osteogenesis. A comprehensive understanding of these mechanisms provides new therapeutic options of osteomyelitis cure and is of great importance in prospective medical treatment. ß
Regulation of bone formation and resorption is a highly complex regulated process. For instance, interruption of bone homeostasis occurring in cancer or infections results in bone loss and impaired bone regeneration. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] Posttraumatic osteomyelitis, which is mainly caused by open fractures, 13, 14 is one of the main issues in this context. Although Staphylococcus aureus and coagulase negative Staphylococcus remain the most common pathogens, an increasing entity of multiresistant germs poses one of the biggest problems in orthopedic surgery. 15 Moreover, curing bone infections requires vast surgical debridement, resulting in large bony defects. 16 It is well accepted that bone infections, especially by S. aureus, cause bone resorption. More precisely, proliferation and mineralization of infected osteoblasts is altered and osteoclast activity is increased in a RANKL-dependent (Receptor Activator of NF-kB Ligand) manner. [8] [9] [10] 12, 17 It is well known that bone regeneration as well as inflammatory processes of bone are regulated by interaction of different cytokines. [18] [19] [20] [21] For example CCL2, also named monocyte chemotactic protein 1 (MCP-1), is known to be released by infected osteoblasts and acts as a strong chemoattractant to monocytes and macrophages. 22, 23 Interestingly, MCP-1 seems to play a role for osteoclast differentiation. 19 Other important proteins within this context are CCL3 and CXCL2, also known as macrophage inflammatory proteins 1a and 2a (MIP-1a and MIP-2a), respectively. These proteins are known to be strong chemoattractants for neutrophils during inflammatory state. 24, 25 Moreover, an important function for osteoclastogenesis and bone resorbing diseases could be observed. 26, 27 Besides that, B cells are known to be potent activators of osteoclastogenesis. 28, 29 Of note, B cell differentiation can be regulated by tissue inhibitor of metalloproteinases 1 (TIMP-1). 30 Our previous study revealed that bone regeneration in posttraumatic osteomyelitis seemed to be still impaired, even after eradication of the basic cause that is, S. aureus. These findings evolved from a new mouse model of posttraumatic osteomyelitis. 31 In this study tibiae of C57BL/6J mice were infected by inoculation of S. aureus. After radical debridement and bacterial eradication, these mice showed significantly diminished formation of new bone in comparison to control group. Moreover, the status of surgical debridement in treatment of bone infections was investigated. 31 Profound knowledge of osteomyelitic markers and causes for diminished bone regeneration after infection is missing.
The current study aims to identify inflammatory markers of post-infectious bone and thereby revealing new treatment strategies, preventing extensive bone loss, and improve bone regeneration. Moreover, reasons for diminished bone regeneration after infection were examined in detail by following various molecular biological approaches.
MATERIALS AND METHODS

Mouse Osteomyelitis Model
All experiments were performed in adherence to the National Institute of Health guidelines for the use of experimental animals and after approval by the German legislation.
The protocol was approved by the LANUV (NRW, Germany; Permit-Number: 84-02.04.2014.A044). Animals were housed and caged individually with free access to water and food under specific pathogen free conditions. About 126 C57BL/6J male and female mice, 12 weeks old with an average weight of 25 g, were used for this project. Surgical steps were performed, as previously described. 31 Briefly, after placement of a skin incision over the proximal medial tibia, a hole (1 mm in diameter) was drilled into the proximal medial tibia. Then S. aureus was injected into the medullary cavity of the tibia. Thereafter, the muscle was reapproximated and the wound closed.
After 2 weeks, second surgery was performed in order to debride the infected bone. After anesthesia and disinfection of the mouse, a skin incision was placed once again over the proximal medial tibia and the bone defect was exposed. Then, infected bone tissue was debrided, followed by rinsing of debrided defects with isotone sodium chloride solution. After debridement, the wound was closed and animals were monitored until recovery from anesthesia. After surgery animals were visited at least two times a day. Especially clinical signs of pain in mice were evaluated, checking for water and food consumption, isolation, and grooming. Moreover, the wound was surveyed thoroughly evaluating wound infections.
Mice were sacrificed 3 and 7 days after debridement (debrided group). Absence of bacteria in debrided bone was verified by agar streak plates. Moreover, specimens of infected animals were taken prior to debridement (pre-debrided day 0).
As a control, all surgical steps were equally performed in healthy C57BL/6J mice, excluding the injection of S. aureus (control group). For control group, animals were injected with bacteria-free medium. We created a figure (Fig. 1) , giving a short overview of different groups within this study. Moreover, Table 1 depicts the number of used animals per group.
Protein Isolation
Tibiae were quick frozen after harvest and stored at À80˚C. After pestling in liquid nitrogen, bone fragments were collected and homogenized in lysis buffer, containing protease inhibitors until lysis was completed. Cellular debris was removed by centrifugation and isolated protein was stored for further experiments.
Cytokine Array
The Proteome Profiler Mouse Cytokine Array Kit, Panel A (Cat.No. ARY006, R&D Systems, Minneapolis, MN) was used to gain an overview of the cytokine profile of treated and control mice. Protein of two animals of each group was isolated and combined as described above. Cytokine array kit was used after manufacturers instructions.
Western Blot
Isolated protein of two animals was combined and mixed with Laemmli sample buffer. A total of six animals per group was used for Western Blot Analysis. After denaturation at 95˚C, samples were kept on ice until loading of the SDS PAGE. About 15% polyacrylamide gels were used for electrophoresis of 30 mg total protein per lane. Protein was transferred to a nitrocellulose membrane using wet transfer method before membranes were blocked with 3% bovine serum albumin to prevent unspecific binding. After washing, membranes were incubated with primary antibodies against CCL2 (2D8), TIMP-1 (F31 P2 A5) ( Figure 1 . Overview of different experimental and control groups. In the upper part (presented in yellow), different experimental groups are depicted, beginning with infected animals before debridement (pre-deb d0), followed by debrided animals 3 days (deb d3) and 7 days (deb d7) after. The same applies to control groups (presented in blue), in the lower part of the figure, showing control animals before debridement (Control d0) and animals 3 days (Control d3) and 7 days (Control d7) after debridement. 
Flow Cytometry
Tibiae were rinsed with phosphate buffered saline containing 10% fetal calve serum using a fine cannula to wash out bone marrow. A single cell suspension was created and cells of two tibiae per group were combined for flow cytometry analysis. 
Histology, Immunohistochemistry, and Immunofluorescence
For all histological procedures, tibiae were taken and fixed in 4% paraformaldehyde solution overnight, decalcified in 19% EDTA solution and finally paraffin embedded. Thereafter, tibiae were longitudinally sectioned at 9 mm. Following, aniline blue staining was performed as previously described. 
Statistics
Results are presented as mean AE standard deviation (SD) of at least three independent experiments. p-values were calculated by unpaired two-tailed student's t-test. For post-hoc comparisons Tukey's test was used. Statistical significances were set at a p-value <0.05.
RESULTS
Surgical Procedure
All animals (126/126) survived the surgical procedures. One animal had to be sacrificed after surgery because of a painful leg fracture and was not included into the study. No postoperative skin infection or fever could be observed.
Inflammatory Profile During Cure of Osteomyelitis Shows Contribution of a Variety of Cytokines
To gain first insights into ongoing inflammatory processes of post-infectious bone regeneration, an inflammation specific cytokine array was performed 3 and 7 days after debridement using non-infected control specimens (see Fig. 2 ). To mimic the surgical situations of removed bacteria and still impaired bone regeneration, specimens were infected by S. aureus inoculation and consecutive bacterial debridement followed by performance of cytokine array 3 and 7 days after debridement (see Fig. 2 ). Moreover, samples of infected animals on day 0 were examined (see Fig. 2 ). These investigations revealed upregulation of certain cytokines such as IL-1a and -1b but also CCL2 and 3, CXCL2 and 9. CCL2 is detected at a very low basal level in non-infected control group and at a persistently high level in both infected and debrided specimens for at least 7 days after DIMINISHED BONE HEALING DEBRIDED OSTEOMYELITIS Figure 2 . Cytokine array of debrided and control group on day 3 and 7 after debridement of osteomyelitis compared to infected bone. The cytokine array represents an overview of inflammation-related cytokines and depicts the cytokine profile of the bone regeneration process. Presented are cytokines expressed in infected osteomyelitic bone on day 0 (pre-deb d0, gray), cytokines of debrided group 3 and 7 days after debridement (deb d3 and 7, gray) and cytokines of non-infected control group 3 and 7 days after debridement (Co d3 and 7, black). CXCL2 and TIMP-1 show highly elevated expression levels in acute infection (pre-deb d0) and debrided group on day 3 in comparison to control. CCL2 and CCL3 link the infection to the innate immune response. Expression of these cytokines is clearly increased in debrided specimens while almost undetectable in control group. Strikingly, TNF-a is solely expressed in infected bone (pre-deb d0) whereas bone resorption in debrided group is not associated to TNF-a expression. Moreover, upregulated levels of CXCL2, CCL2, and CCL3 are found 7 days after debridement of osteomyelitis while control group exhibits no basal expression of these particular cytokines. Additionally, no TNF-a regulation was traceable 7 days after debridement in debrided and control group further consolidating the cytokine profile on day 3 after debridement.
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debridement. CCL3 levels are highest in infected specimens on day 0, decrease over time from day 3 to day 7 after debridement and are not detectable in control group. Also culminating in infected specimens on day 0, CXCL2 levels are increasing throughout the bone regeneration process from day 3 to 7 after debridement. TNF-a was solely detectable in infected animals on day 0 but not in debrided or control animals. Besides that, TIMP-1 was upregulated in debrided group and persists at clearly higher levels than non-infected control group for at least 7 days after debridement.
Early Inflammation in Osteomyelitis Is Closely Correlated to Innate Immune Response
The integration of the innate immune system in osteomyelitic bone after debridement was further characterized on the protein level. Monocyte chemotactic protein 1 (MCP-1, also known as CCL2) is expressed by monocytes during infectious events. In non-infected control group, only low levels of CCL2 were found whereas in debrided specimens, CCL2 expression remained at a high level for at least 7 days (see Fig. 3 ). CCL3, also known as macrophage inflammatory protein 1-a, is rapidly expressed during acute Figure 3 . Significant alterations of protein expression levels between debrided and control group are verified by Western Blot analysis. Selected cytokines that play a tremendous role during bone regeneration were detected during acute infection (pre-debrided d0) and beginning bone healing after debridement of osteomyelitis on day 3 and 7 in debrided and control group, respectively. Analysis of CCL2 reveals constantly increased expression in debrided group significantly surmounting basal levels of control group. Acute infection is also connected to a rapid, transient rise of CCL3 expression in debrided group that diminishes with initiation of bone healing. Control group shows no basal CCL3 expression. An additional link to the innate immune response is represented by CXCL2 whose expression in debrided group is also significantly exceeding control levels from d0 until d7 after debridement. RANKL is a key factor in osteoclastogenesis, thus upregulated RANKL expression in debrided group promotes bone degradation. Control group represents basal RANKL expression levels. TIMP-1 expression remains significantly increased compared to control group from d0 until d7. Solely state of acute infection is associated to TNF-a expression (pre-debrided d0). Bone healing in both control group and debrided group (d3 and d7) is not related to any TNF-a expression. Results are shown as mean of pixel counts AE SD of duplicates of three independent experiments. p-value: Ã < 0.05, ÃÃ < 0.01, ÃÃÃ < 0.001.
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inflammation. The chemokine expression occurs transiently as the CCL3 level drops from day 3 to 7 after debridement (see Fig. 3 ). Control groups did not show any CCL3 expression. Related to CCL3, CXCL2 also known as macrophage inflammatory protein 2-a, is secreted by monocytes and macrophages and is therefore, strongly involved in the innate immune response (see Fig. 3 ). The osteoclast differentiation factor RANKL is essential for consideration of bone regeneration and remodeling. RANKL promotes osteoclastogenesis, therefore, stimulating bone degradation. Conversely, increased protein expression levels of RANKL have been detected during bone regeneration of debrided group (see Fig. 3 ). TIMP-1 levels likewise remain elevated for at least 7 days in debrided group thus surmounting basal TIMP-1 levels of non-infected control group significantly (see Fig. 3 ). Thus, although the causing pathogen that is, S. aureus was eradicated, there seem to be a prolonged inflammatory response in debrided bone.
Bone Healing Is Mostly Independent of TNF-a Signaling
The acute phase reaction of an inflammation is closely correlated to TNF-a and associated signaling. This cytokine is mostly produced by activated macrophages and plays a significant role in regulating immune cells. Interestingly, TNF-a expression was solely traceable in the acute infection of osteomyelitis on day 0. Likewise non-infected control group and debrided group did not show TNF-a expression (see Fig. 3 ).
B Cells Are Elevated in Debrided Acute Osteomyelitic Bone
In order to investigate to what extent the cellular immune system is involved in this altered balance of post-infectious bone regeneration, FACS analysis of debrided bone samples was performed. Immunocompetent T cells, B cells and granulocytes were examined. Flow cytometry revealed significantly elevated levels of CD19 þ B cells in both infected (pre-debrided d0) and debrided specimens 3 and 7 days after debridement compared to non-infected control while total number of B cells dropped over the time course (see Fig. 4A ). Of note, no significant differences were found when analyzing CD3
þ T cells and Gr-1 þ granulocytes (data not shown).
Additionally, immunohistochemical stainings against CD-19 mirrored FACS results by detecting substantially increased B cell numbers in infected (pre-debrided d0) specimens decreasing with progression of bone healing over time from day 3 to day 7 after debridement but still exceeding basal levels of non-infected control group continuously (see Fig. 4B ). Histomorphometric analysis confirms these differences and shows statistical significance (see Fig. 4C ).
Osteoblast Differentiation and Proliferation Is Diminished in Osteomyelitis
The diminished bone healing capacity of post-infectious bone was subsequently characterized by immunohistochemical stainings against PCNA, RUNX2, and Osteocalcin. Analysis of PCNA expression showed markedly reduced PCNA occurrence compared to non-infected control group, illustrating limited proliferation on day 3 and 7 in debrided group after flourishing proliferation on day 0 (see Fig. 5A ). Moreover, continuously decreased levels of RUNX2 are found during early bone regeneration in debrided tibiae for at least 7 days (see Fig. 5B ). A similar trend is revealed when comparing non-infected control and . Seven days after debridement, debrided group (debrided d7) still shows enhanced B cells compared to control d7. These differences were statistically significant on day 3 (A). Immunofluorescent staining against CD19 confirms differing amounts of CD19 þ B cells in debrided and control group, respectively (B). B cells are continuously elevated during acute infection (pre-debrided day 0) and initial bone healing (debrided day 3 and 7) compared to control group. This trend is further emphasized by histomorphometric analysis (C). Ordinate shows number of counted pixels. Results are shown as mean AE SD. p-value:
Ã < 0.05 (A, C), Scale bar: 100 mm (B).
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debrided specimens for Osteocalcin as indicator of late bone regeneration (see Fig. 5C ).
Increased Osteoclast Activity in Debrided Defects
In order to examine osteoclast activity, immunohistochemical stainings against Calcitonin-receptor (CTR) were performed on days 0, 3, and 7 of debrided and noninfected control group. These data show significantly more osteoclast activity on day 3 within debrided group and pre-debrided group (see Fig. 6 ). Of note, more osteoclasts were found in control group on day 7 as remodeling of new formed bone occurs Fig. 7 .
DISCUSSION
Diminished bone healing after osteomyelitic infections is a common clinical issue of orthopedic surgery. 33 Even after sufficient debridement, bone regeneration seemed to be decreased, although the direct cause has been completely removed. 31 Thus the aim of this study was to reveal further details of the diminished bone regeneration after posttraumatic osteomyelitis.
Increased osteoclast activity is one of the reasons for bone resorption during infections. This process is regulated by a whole armada of cytokines, for example CCL2, which is known to be expressed by osteoblasts in infected bone. 22 Of note, CCL2 is not expressed in normal bone, but is a potent mediator during osseous inflammation. 22 During fracture healing, CCL2 is involved in bone remodeling, upregulating osteoclast activity by stimulation of osteoclast differentiation at late fracture healing. 19, 34 Of note, elevated levels of CCL2 are associated with inflammatory bowel diseases like rheumatoid arthritis. 35 In addition, CXCL2 and CCL3 are potent mediators for activation of osteoclasts. 26, 27 More specifically, CXCL2, also activated by RANKL expression, is important for osteoclastogenesis and only expressed during early time points of fracture healing. 36, 37 Typically, these cytokines are regulated by TNF-a but evidence was found for an alternative TNF-a-independent activating pathway within acute inflammatory state. 38 Interestingly, patients with implant-associated osteomyelitis showed elevated expression of CCL3 and CXCL2, leading to increased osteoclast activity and bone erosion. 9 To sum it up, cytokines are closely related to inflammation. Therefore, we analyzed the expression of inflammation specific cytokines and found significant differences between debrided and non-infected control groups verified by a cytokine array and complementary Western Blot analysis. In accordance to these findings, increased levels of CCL2, CCL3, and CXCL2 were detected during the acute inflammatory state, but still remained accelerated after debridement throughout the whole bone regeneration process. Interestingly, in control group CCL2 was detectable on a low baseline and CXCL2 was only detectable during early fracture healing, which represents a physiological condition of bone Figure 5 . Osteogenesis is severely impaired within status of post-infectious bone healing. Immunohistochemical staining against proliferation marker PCNA reveals initial increase of PCNA in acute infection (pre-debrided day 0) compared to control (A). This condition of highly proliferative status switches after debridement and progress of bone remodeling (A). PCNA expression is diminished on day 3 and 7 in debrided group compared to non-infected control. This finding confirms impaired proliferation in post-infectious bone. Osteogenic marker RUNX2 is persistently decreased during process of infection and subsequent recovery. Immunofluorescent staining against RUNX2 depicts diminished osteogenesis in debrided group, beginning on day 0 and lasting until day 3, and 7 compared to control group (B). Severely impaired osteogenesis is further proved by considerably decreased Osteocalcin expression. Immunohistochemical staining against Osteocalcin supports the finding of dramatically compromised osteogenesis in debrided group throughout the whole observation period (C). Lowered levels of Osteocalcin are depicted on day 0, 3, and 7 in debrided group compared to control group. Scale bar: 200 mm (A, E), scale bar: 100 mm (C), ordinate shows number of counted pixels. Results are shown as mean AE SD. p-value:
DIMINISHED BONE HEALING DEBRIDED OSTEOMYELITIS regeneration. 34, 39 Consequently, elevated levels of RANKL were present. Thus we assume a RANKLdependent activation of osteoclasts mediated by these cytokines, even after surgical therapy of bone inflammation, as a cause for diminished bone regeneration.
Interestingly, TNF-a which is a central mediator of inflammatory diseases, especially in the context of bone erosion, 40, 41 was upregulated in infected bone (day 0), but did not influence bone regeneration after debridement indicated by the absence of TNF-a in debrided groups. Therefore, we hypothesize a TNF-a-independent mechanism of bone resorption after cure of osteomyelitis hat appears mainly controlled by RANKL.
In the context of increased osteoclast activity, B cells are believed to play a crucial role for osteoclast activity and focal bone erosion. 28, 29, 42, 43 Here, we demonstrated significantly increased B cell population during bone regeneration after debridement of osteomyelitis by using immunofluorescent stainings and FACS analysis.
Upcoming evidence proves the role of B cells during inflammatory bowel diseases, like rheumatoid arthritis, to increase osteoclast activity and thereby accelerate bone resorption. 43 Therefore, it is likely to presume inhibition of bone regeneration by B cells via osteoclast activation after debridement of osteomyelitis. In addition, TIMP-1 is known to be an important factor for differentiation of germinal B cells, 30, 44 thus a possible mechanistic coincidence is supposed. This hypothesis is supported by elevated expression of TIMP-1 after debridement of osteomyelitic bone.
In this study, immunohistochemical stainings against Calcitonin-receptor (CTR) and PCNA revealed increased osteoclast activity correlating with elevated proliferation during the acute inflammatory state of the bone (day 0). Interestingly, during early fracture healing (day 3) proliferation is severely impaired after sufficient debridement of osteomyelitis, while osteoclast activity is still increased. Additional tracking of Osteocalcin indicated reduced osteogenesis after cured bone infection accompanied with diminished expression of RUNX2. This leads to the assumption of a decreased osteoblast activity due to the lack of RUNX2.
There are numerous studies dealing with therapeutic options for osteomyelitis, [45] [46] [47] but only a few examining bone regeneration within this context. 48 Figure 6. Initial increase of Calcitonin-receptor during acute infection and early bone healing is reversed 7 days after debridement. Calcitonin-receptor (CTR) is indicative of osteoclastogenesis. Immunohistochemical staining against CTR demonstrates transient upregulation of CTR in debrided group on day 0 and 3. Control group remains CTR-negative on day 0 and day 3, respectively. On day 7 after debridement, CTR level declines in debrided group while more signal is detectable in control group as remodeling of bone occurs within the process of bone regeneration. Histomorphometric analysis further supports the significant elevation of osteoclast marker CTR in debrided group on day 0 and 3, whereas this finding reverses on day 7 after debridement. Scale bar: 100 mm (A), Ordinate shows number of counted pixels. Results are shown as mean AE SD. p-value:
Ã < 0.05 (B).
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For example Guelcher et al. showed the pro-osteogenic effects of BMP-2 and Vancomycin-loaded scaffolds in an osteomyelitis rat femur defect model. 48 This study showed first insights into the inflammatory environment of diminished bone healing after debridement of osteomyelitis.
Thereby, two cooperating mechanisms are proposed: increased osteoclast activity paired with decreased osteoblast activity. Likewise, various causes are illustrated, leading to an increased osteoclast activity. Resulting potential therapeutic targets are specifically involved cytokines like CCL2, CCL3, and CXCL2 whose manipulation could serve to modulate bone regeneration in order to improve this process. Moreover, increased B cell numbers represent another interesting treatment aspect for reduction of osteoclast activity and thereby deceleration of bone resorption.
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